This effect of simvastatin was seen by day 7 (p = 0.008), with maximal reduction seen at day 14 (p = 0.004; hs-CRP in original units 3.1 ± 0.5 mg/L with simvastatin and 4.1 ± 0.6 mg/L with placebo).
On day 1, the absolute lymphocyte count (ALC) declined with the maximal reduction observed at approximately 4 6 h post dose.
Maximal reduction was observed at the middle (1 mg/kg) dose.
There was a significant correlation between maximal reduction in SICI at ISI 3 ms and the decline in force generated by thumb abduction (R = −0.4, P < 0.05, Fig. 4).
Fasting blood glucose was also decreased in the two recent canagliflozin studies, but showed a slight progressive decrease after the maximal reduction was observed at weeks 4 [ 5] and 6 [ 6].
Forty-eight hours was determined to be the optimal time of drug exposure because there was the maximal reduction in cell number at this time point for all three drugs (Supplementary Figure S1).
The results, shown in Figure 6, indicate that Cmax was achieved at one hour post dose, maximal reduction of brain Aβ was observed at three hours post dose, and significant reduction was maintained at 10 hours post dose at all doses tested (28%, 33%, and 56%, at 30, 100, and 300 mg/kg, respectively).
In the case of the reduction of PF, the maximal reduction activity was also obtained at the same light intensity (data not shown).
As recently shown, the use of newer improved EPI technology, dedicated surface coils and optimized sequences enables a maximal reduction of EPI-related artefacts at a relatively high spatial resolution [ 8, 23– 27].
In vivo examination of 22 in an acute intraperitoneal glucose tolerance test (IPGTT) in normal mice revealed a good dose dependent response with maximal reduction in glucose level reached at 50 mg/kg.
